Global Bone Morphogenetic Proteins Sales Market Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Bone Morphogenetic Proteins Sales Market Report 2024
Market Analysis and InsightsGlobal Bone Morphogenetic Proteins Market
Bone morphogenetic proteins (BMPs) are a group of growth factors also known as cytokines and as metabologens.Originally discovered by their ability to induce the formation of bone and cartilage, BMPs are now considered to constitute a group of pivotal morphogenetic signals, orchestrating tissue architecture throughout the body.
Due to the COVID-19 pandemic, the global Bone Morphogenetic Proteins market size is estimated to be worth US$ 431.1 million in 2024 and is forecast to a readjusted size of US$ 495.6 million by 2034 with a CAGR of 2.5% during the forecast period 2024-2034. Fully considering the economic change by this health crisis, rhBMP-2 accounting for % of the Bone Morphogenetic Proteins global market in 2024, is projected to value US$ million by 2034, growing at a revised % CAGR from 2023 to 2034. While Spinal Fusion segment is altered to an % CAGR throughout this forecast period.
The United States Bone Morphogenetic Proteins market is estimated at US$ million in 2024, while China was US$ million. The proportion of the United States is % in 2024, while Chinese percentage was %, and it is predicted that China share will reach % in 2034, trailing a CAGR of % through the analysis period.
The global key manufacturers of Bone Morphogenetic Proteins include Medtronic, Cellumed, Stryker, Sigma Aldrich, ProSpec, Ember therapeutics, R&D Systems and Thermo Fischer, etc. In 2024, the global top five players occupied for a share approximately % in terms of revenue.
In United States, in terms of sales revenue, in 2024, the top three players hold a share about %, while in China, top three players hold a share nearly %.
Global Bone Morphogenetic Proteins Scope and Market Size
The global Bone Morphogenetic Proteins market is segmented by company, region (country), type and application. Players, stakeholders, and other participants in the global Bone Morphogenetic Proteins market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), type and application for the period 2018-2034.
Segment by Type
rhBMP-2
rhBMP-7
Spinal Fusion
Trauma
Reconstructive Surgery
Oral-Maxillofacial
Others
By Region
United States
Europe
China
Japan
Southeast Asia
India
Other Regions
Medtronic
Cellumed
Stryker
Sigma Aldrich
ProSpec
Ember therapeutics
R&D Systems
Thermo Fischer
Bone morphogenetic proteins (BMPs) are a group of growth factors also known as cytokines and as metabologens.Originally discovered by their ability to induce the formation of bone and cartilage, BMPs are now considered to constitute a group of pivotal morphogenetic signals, orchestrating tissue architecture throughout the body.
Due to the COVID-19 pandemic, the global Bone Morphogenetic Proteins market size is estimated to be worth US$ 431.1 million in 2024 and is forecast to a readjusted size of US$ 495.6 million by 2034 with a CAGR of 2.5% during the forecast period 2024-2034. Fully considering the economic change by this health crisis, rhBMP-2 accounting for % of the Bone Morphogenetic Proteins global market in 2024, is projected to value US$ million by 2034, growing at a revised % CAGR from 2023 to 2034. While Spinal Fusion segment is altered to an % CAGR throughout this forecast period.
The United States Bone Morphogenetic Proteins market is estimated at US$ million in 2024, while China was US$ million. The proportion of the United States is % in 2024, while Chinese percentage was %, and it is predicted that China share will reach % in 2034, trailing a CAGR of % through the analysis period.
The global key manufacturers of Bone Morphogenetic Proteins include Medtronic, Cellumed, Stryker, Sigma Aldrich, ProSpec, Ember therapeutics, R&D Systems and Thermo Fischer, etc. In 2024, the global top five players occupied for a share approximately % in terms of revenue.
In United States, in terms of sales revenue, in 2024, the top three players hold a share about %, while in China, top three players hold a share nearly %.
Global Bone Morphogenetic Proteins Scope and Market Size
The global Bone Morphogenetic Proteins market is segmented by company, region (country), type and application. Players, stakeholders, and other participants in the global Bone Morphogenetic Proteins market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), type and application for the period 2018-2034.
Segment by Type
rhBMP-2
rhBMP-7
Segment by Application
Spinal Fusion
Trauma
Reconstructive Surgery
Oral-Maxillofacial
Others
By Region
United States
Europe
China
Japan
Southeast Asia
India
Other Regions
By Company
Medtronic
Cellumed
Stryker
Sigma Aldrich
ProSpec
Ember therapeutics
R&D Systems
Thermo Fischer
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices